Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman
OMOutset Medical(OM) GlobeNewswire News Room·2024-09-01 05:52

SAN FRANCISCO, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Hagens Berman Outset Medical (NASDAQ: OM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys. Class Period: Aug. 1, 2022 – Aug. 7, 2024Lead Plaintiff Deadline: Oct. 28, 2024Visit: www.hbsslaw.com/investor-fraud/om Contact the Firm Now: OM@hbsslaw.com 844-916-0895 Outset Medical, Inc. (OM) Securities Class Action: The litigation focuses ...